Viz.ai

In intracerebral hemorrhage, getting the right patient to the right team fast is the difference between recovery and permanent disability. In one case study, Viz ICH+ cut interhospital transfer time from ~200 minutes to 101 minutes — nearly in half. That's the kind of clinical evidence that earned Viz.ai the #1 ranking in Clinical Evidence, Validation & Outcome Support in the 2026 Black Book survey. Read the publication: https://lnkd.in/gjQtsibC

After deploying an AI platform with 50+ algorithms across 2,000 hospitals, you learn a lot. This week in NEJM AI I was fortunate to team up with my colleague Meghana Valluri from our Product team at Viz.ai to share our learnings over decade of putting AI into the clinical workflow. "Unfortunately, this story is not unique to sub-types of heart failure, or even cardiology more broadly. You can find it in every corner of the health care system: a condition presents with symptoms easily mistaken for something far more common, the clinician reasonably treats what it looks like, the patient does not quite get better, and the search quietly stops at a diagnosis that was good enough to move on from. Every clinician — the pulmonologist, the neurologist, the generalist — face their own version of the same challenge. It reflects the modern state of medicine — we have far more diagnoses to choose from, and more inputs to integrate to choose the right one. And it is precisely where AI tools can deliver. But getting them adopted goes far beyond a successful algorithm." https://lnkd.in/gsh4eJwU

🔜 On October 1, we're bringing senior life sciences leaders, clinical experts, and health system executives together to explore how AI is becoming part of routine care, and what this shift requires of pharma commercial, medical, and brand teams. Check out the full list of speakers and attendees here: https://lnkd.in/es4EnPqK

Pulmonary care has been split across tools that don't talk to each other. PE risk in one place, COPD follow-up in another, nodules tracked wherever there was room. Viz Pulmonary Suite is built specifically for pulmonologists: one connected platform across PE, COPD and lung nodules, with deep EHR integration surfacing chart context inside the workflow. Come see how this works in our first year at CHEST. We will be at booth #598, 18–21 October in Phoenix. Book a time with us: https://lnkd.in/gGGft9ss #CHEST2026 #Pulmonology #HealthcareAI

🌟 September Viz MVP Spotlight: Shannon Coveney 🌟 As a Regional Sales Manager, Shannon brings tremendous dedication, consistency, and persistence to her work every day. Drawing on her clinical background, she works closely with many strategic accounts, building strong relationships, understanding what matters most to each customer, and helping them advance their goals and make a meaningful impact. Shannon, thank you for everything you bring to this team. The results speak for themselves, but it's the way you do the work that truly makes you stand out. We're so grateful to have you. 👏 #EmployeeRecognition #TeamViz #AIinHealthcare

Clinical guidelines are continually evolving, and AI can help care teams keep pace and make the latest evidence more actionable for each patient, without adding more manual work. At Viz.ai, we’re already bringing NCCN® Guidelines into oncology workflows and GOLD guidelines into COPD care, using patient-specific clinical information to surface relevant, evidence-based recommendations in the flow of care. Looking forward to hearing our Chief Medical Officer Tim Showalter and peers discuss How Guidelines are Being Embedded in Clinical AI in the upcoming NEJM AI Webinar October 21. Register here: https://lnkd.in/gvinAsGU

Viz.ai was mentioned on The Wall Street Journal's All Things podcast where host Kim Strassel and columnist Andy Kessler discussed how the Viz.ai care coordination platform flags at-risk patients in the hospital. As Kessler put it, "they have a system that's set up to flag in hospital patients....From the day they put it in, it started saving lives. That's the kind of thing that these companies should be talking about." Moments matter in healthcare. Viz.ai exists to get the right information to the right clinician, faster, so care teams can act when it counts. This is why we keep building and why the conversation about responsible AI, including the guardrails to manage its risks, matters just as much as the innovation itself. 🎧 Access the full episode: https://lnkd.in/dTFXV2md #AIforGood #HealthTech #Vizai #WSJ

September is Brain Aneurysm Awareness Month. At Viz.ai, we stand with those living with a brain aneurysm, survivors, and families who have lost someone they love. AI powered care coordination can help clinicians identify suspected brain aneurysms on imaging and connect patients with specialists for evaluation, ongoing monitoring, and treatment when appropriate. This month, we recognize the clinicians, caregivers, and advocacy organizations advancing research, expanding education, and supporting patients and families. Join us in raising awareness and supporting the brain aneurysm community. #BrainAneurysmAwarenessMonth #CareCoordination #Vizai

🎉 Viz.ai has been named to TIME's World's Top HealthTech Companies of 2026 list! We're proud to be recognized with an "Outstanding" performance rating in the Health Information & Management category — one of six market segments TIME and Statista evaluated across financial performance, reputation, and online engagement to identify the 500 most impactful health tech companies worldwide. This recognition reflects the work our entire team puts in every day to help care teams detect disease earlier, coordinate faster, and get patients the treatment they need — powered by the Viz.ai One Platform. Thank you to our customers, partners, and the Viz.ai team for making this possible. Onward! 🚀 Read the full list: https://lnkd.in/gMr_6s_V #HealthTech #DigitalHealth #AI #Healthcare #Innovation